Biotek-snakken — Marts 2022
-
Sanofi og Sobi når vigtige mål i fase 3-studie af blødermidel https://proinvestor.com/investornyt/792726/sanofi-og-sobi-nar-vigtige-mal-i-fase-3-studie-af-blodermidel
-
-
Ser ud til Pzifer har søgt en Form 25 og pilles af børsen, men mangler at få det bekræftet https://www.sec.gov/Archives/edgar/data/78003/000087666122000258/xslF25X02/primary_doc.xml
-
Stenocare med opjustering. https://www.proinvestor.com/boards/101869
-
Zealand Pharma i nyt underskud - ser omkostninger på 1,2 mia kr i 2022 https://proinvestor.com/investornyt/793587/zealand-pharma-i-nyt-underskud-ser-omkostninger-pa-12-mia-kr-i-2022
-
Orphazyme: Søger retlig beskyttelse til restrukturering - NY - GENT https://proinvestor.com/investornyt/794021/orphazyme-soger-retlig-beskyttelse-til-restrukturering-ny-gent
-
Zealand Pharma/Nordea: Sænker kursmål med en tyver https://proinvestor.com/investornyt/794047/zealand-pharma-nordea-saenker-kursmal-med-en-tyver
-
Zealand Pharma/Danske: Sænker kursmål til 250 kr. fra 285 kr. https://proinvestor.com/investornyt/794062/zealand-pharma-danske-saenker-kursmal-til-250-kr-fra-285-kr
-
Are Biotech Stocks a Good Investment for Retirement? https://proinvestor.com/investornyt/794662/are-biotech-stocks-a-good-investment-for-retirement
-
Zealand/Jefferies: Gentager "køb" op til flere vigtige milepæle https://proinvestor.com/investornyt/794795/zealand-jefferies-gentager-kob-op-til-flere-vigtige-milepaele
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind